Fort LP’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,984
Closed -$232K 186
2022
Q3
$232K Sell
5,984
-3,818
-39% -$153K 0.29% 181
2022
Q2
$365K Sell
9,802
-2,346
-19% -$95.5K 0.25% 184
2022
Q1
$538K Buy
12,148
+7,208
+146% +$312K 0.2% 202
2021
Q4
$210K Buy
+4,940
New +$208K 0.07% 282
2020
Q3
Sell
-8,564
Closed -$301K 297
2020
Q2
$301K Sell
8,564
-5,417
-39% -$195K 0.16% 221
2020
Q1
$456K Sell
13,981
-3,495
-20% -$137K 0.1% 245
2019
Q4
$790K Sell
17,476
-13,589
-44% -$569K 0.14% 221
2019
Q3
$1.26M Buy
31,065
+5,498
+22% +$233K 0.24% 182
2019
Q2
$1.1M Sell
25,567
-4,425
-15% -$170K 0.21% 189
2019
Q1
$1.15M Buy
29,992
+8,102
+37% +$309K 0.23% 185
2018
Q4
$774K Buy
21,890
+11,988
+121% +$435K 0.18% 196
2018
Q3
$381K Buy
9,902
+8,302
+519% +$290K 0.09% 231
2018
Q2
$52K Buy
+1,600
New +$48.3K 0.01% 226

Other funds holding BSX

Fort LP's BSX Position: Q4 2022 in Review

Fort LP sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 5,984 shares — an estimated $232K sold.

Fort LP first reported a position in BSX in Q2 2018 and held it in 13 quarters. The position peaked at $1.26M in Q3 2019. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Fort LP reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • Fort LP sold 5,984 Boston Scientific shares in Q4 2022, an estimated $232K.
  • Fort LP first reported a position in Boston Scientific in Q2 2018 and held it in 13 quarters.
  • Fort LP's Boston Scientific position peaked at $1.26M in Q3 2019.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Fort LP's 13F filing for Q4 2022, filed 13 Feb 2023.